Does Taysha Gene Therapies Inc (TSHA) Have What it Takes to be in Your Portfolio Friday?

A rating of 89 puts Taysha Gene Therapies Inc (TSHA) near the top of the Biotechnology industry according to InvestorsObserver. Taysha Gene Therapies Inc's score of 89 means it scores higher than 89% of stocks in the industry. Taysha Gene Therapies Inc also received an overall rating of 72, putting it above 72% of all stocks. Biotechnology is ranked 46 out of the 148 industries.

TSHA has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on TSHA!

See Full TSHA Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Taysha Gene Therapies Inc Stock Today?

Taysha Gene Therapies Inc (TSHA) stock is higher by 0.57% while the S&P 500 is down -0.04% as of 10:55 AM on Friday, Dec 1. TSHA is up $0.01 from the previous closing price of $1.76 on volume of 150,063 shares. Over the past year the S&P 500 is up 12.01% while TSHA is down -18.81%. TSHA lost -$2.58 per share the over the last 12 months. Click Here to get the full Stock Report for Taysha Gene Therapies Inc stock.